cyclophosphamide,fludarabine
Showing 1 - 5 of 5
CD19+ and CD 22+ B-ALL Trial in Langfang (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells, Cyclophosphamide,Fludarabine)
Recruiting
- CD19+ and CD 22+ B-ALL
- Autologous CD19/CD22 Chimeric Antigen Receptor T-cells
- Cyclophosphamide,Fludarabine
-
Langfang, Hebei, ChinaHebei Yanda Ludaopei Hospital
Jan 25, 2022
Hodgkin's Lymphoma Trial in Shijiazhuang (biological, drug, procedure)
Recruiting
- Hodgkin's Lymphoma
- Auto CAR-T
- +2 more
-
Shijiazhuang, Hebei, ChinaHematology Department, Hebei Medical University Fourth Hospital
Dec 24, 2020
Plasma Cell Tumors Trial in Shijiazhuang (biological, drug, procedure)
Recruiting
- Plasma Cell Tumors
- Auto CAR-T
- +2 more
-
Shijiazhuang, Hebei, ChinaHematology Department, Hebei Medical University Fourth Hospital
Dec 7, 2020
Non-hodgkin's Lymphoma Trial in Shijiazhuang (biological, drug, procedure)
Recruiting
- Non-hodgkin's Lymphoma
- Auto CAR-T
- +2 more
-
Shijiazhuang, Hebei, ChinaHematology Department, Hebei Medical University Fourth Hospital
Dec 7, 2020
Leukemia, Lymphoma Trial in Shijiazhuang (biological, drug, procedure)
Recruiting
- Leukemia
- Lymphoma
- Auto CAR-T
- +2 more
-
Shijiazhuang, Hebei, ChinaPediatric hematology, Hebei Medical University Fourth Hospital
Oct 29, 2020